Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis

Author(s): Evangelou N, Konz D, Esiri MM, Smith S, Palace J, et al.

Abstract

Previous imaging studies have suggested that there is substantial axonal loss in the normal-appearing white matter (NAWM) of brains from multiple sclerosis patients and that this axonal loss may be an important determinant of disability. Recently, substantial axonal loss in the NAWM has been confirmed directly in post-mortem tissue. Whether the NAWM changes occur as a consequence of damage to axons traversing lesions or to a more diffuse injury process is uncertain. Using formalin-fixed brains of eight multiple sclerosis patients and eight age-matched controls, we examined the relationship between demyelinating lesion load in three volumes of the cerebral white matter and the loss of axons in NAWM of the corresponding three projection regions (anterior, middle, posterior) in the corpus callosum (CC). There was a significant loss of calculated total number of axons crossing the CC in each of the three regions relative to the non-multiple sclerosis controls. Strong correlations were found between the regional lesion load and both the axonal density (r = -0.673, P: = 0.001) and the total estimated number of axons crossing the corresponding projection area in the CC (r = -0. 656, P: = 0.001) for the patients. This suggests that Wallerian degeneration of axons transected in the demyelinating lesions makes a major contribution to the substantial, diffuse loss of axons in the NAWM in multiple sclerosis. These findings emphasize the need to consider the consequences of multiple sclerosis lesions in terms of both local and distant effects in functionally connected regions of the brain.

Similar Articles

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study

Author(s): Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, et al.

Axonal transection in the lesions of multiple sclerosis

Author(s): Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, et al.

Magnetic resonance frequency shifts during acute MS lesion formation

Author(s): Wiggermann V, Hernández Torres E, Vavasour IM, Moore GR, Laule C, et al.

Weekly diffusion-weighted imaging of normal-appearing white matter in MS

Author(s): Rocca MA, Cercignani M, Iannucci G, Comi G, Filippi M

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

Author(s): van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, et al.

MRI in multiple sclerosis: current status and future prospects

Author(s): Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, et al.

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T

Author(s): Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, et al.

Diffusion tensor magnetic resonance imaging in multiple sclerosis

Author(s): Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G

Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis

Author(s): Narayana PA, Zhou Y, Hasan KM, Datta S, Sun X, et al.

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis

Author(s): Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, et al.

Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis

Author(s): Radü EW, Bendfeldt K, Mueller-Lenke N, Magon S, Sprenger T

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Author(s): Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al.

Clinical correlations of brain lesion distribution in multiple sclerosis

Author(s): Vellinga MM, Geurts JJ, Rostrup E, Uitdehaag BM, Polman CH, et al.

Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR

Author(s): van Waesberghe JH, van Walderveen MA, Castelijns JA, Scheltens P, Lycklama à Nijeholt GJ, et al.

Measuring myelin repair and axonal loss with diffusion tensor imaging

Author(s): Fox RJ, Cronin T, Lin J, Wang X, Sakaie K, et al.

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

Author(s): Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, et al.

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis

Author(s): Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, et al.

Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features

Author(s): Tubridy N, Coles AJ, Molyneux P, Compston DA, Barkhof F, et al.

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

Author(s): Barkhof F, Held U, Simon JH, Daumer M, Fazekas F, et al.

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis

Author(s): Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, et al.